NASDAQ:WGS 16 December 2025

GeneDx stock drops again: WGS slides on 2026 outlook as JPM talk nears

GeneDx shares fell 8.7% to $108.90 Tuesday afternoon after the company released a 2026 revenue forecast of $540 million to $555 million and projected positive adjusted net income. The company reported 2025 revenue of about $427 million and ended the year with $172 million in cash. Investors are watching for updates at the J.P. Morgan Healthcare Conference on Jan. 14.

13 January 2026

Biotechnology·NASDAQ:WGS·Stock Market

GeneDx (WGS) Stock Slides on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching Next

GeneDx Holdings shares fell nearly 7% to around $140 intraday Tuesday after closing near $150.6. Trading volume was below average, with no major news driving the drop. The move followed a recent JAMA recognition for the company’s GUARDIAN newborn genomic screening study and several analyst price target hikes earlier in the week. Broader U.S. markets were also under pressure.

16 December 2025

NASDAQ:WGS·Stock Market

NASDAQ:WGS 16 December 2025 - 13 January 2026

GeneDx stock drops again: WGS slides on 2026 outlook as JPM talk nears

GeneDx (WGS) Stock Slides on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching Next

Latest article

ASX 200 hits record close after strong week — what to watch next in Australian stocks

TSX logs best month since 2020, then slips Friday: what Toronto Stock Exchange investors watch next week

Shenzhen stocks finish the week higher — but ChiNext slides as Beijing policy week looms

Nifty slips below 25,200 to end week down 1.5% on NSE; GDP reset, PMIs in focus

Popular

Pure Storage (PSTG) Stock Drops After Q3 FY26 Earnings as Wall Street Weighs AI Investment and Rich Valuation

Shell share price edges higher in London as Nigeria incentives and Argentina shale sale talk hit the tape